Marnie Bertolet

Marnie Bertolet, PhD, serves as Associate Professor in Biostatistics at the University of Pittsburgh with secondary appointments in Epidemiology and affiliation with the Clinical & Translational Science Institute. Her research bridges maternal-child health, aging trajectories, health equity, and cardiovascular clinical trials through advanced biostatistical methodologies.

Her educational foundation includes:

• BA in Mathematics from Shippensburg University (1993)
• MEng in Operations Research and Industrial Engineering from Cornell University (1995)
• MS in Statistics from Carnegie Mellon University (2002)
• PhD in Statistics from Carnegie Mellon University (2008)

Dr. Bertolet investigates maternal factors influencing preterm birth and long-term cardiovascular outcomes, pregnancy-related impacts on dementia risk, and health disparities through subgroup analyses in Black populations. Her biostatistical expertise drives innovations in transfusion medicine and cardiovascular trial design, particularly for anemia management in myocardial infarction.

Analysis of her 2022-2025 publications reveals dominant themes in cardiovascular outcomes optimization (transfusion thresholds, biomarker dynamics), maternal health epidemiology, and neurodegenerative health disparities. Methodologically, her work leverages target trial emulation, longitudinal modeling, and subgroup analysis to address complex clinical questions.

Her diversity contributions are recognized through:

• Certificate in Diversity and Inclusion
• Diversity in the Curriculum award for integrating equity into clinical trial coursework

As lead statistician for NIH-funded trials including MINT, BARI 2D, SCD-CARRE, Wheel Chair 2, and SPARC, she designs DSMB monitoring protocols and analytical frameworks for multicenter studies. Her teaching in machine learning and Bayesian analysis further extends methodological impact.

She collaborates extensively with interdisciplinary teams across institutions, contributing biostatistical leadership to cardiovascular, maternal health, and neurodegenerative research consortia.